IL6 and COVID-19: Pathology during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection appears to arise at least in part from an excessive inflammatory response with a key role for the cytokine interleukin (IL)-6, which is consistently upregulated in severe COVID-19 (1–3).